ISID Home
11th ICID
Welcome
Congress Committees
Scientific Program
 - Plenary Lectures
 - Symposia
 - Satellite Symposia
 - Acknowledgements
Congress Organization
Congress Archive
ProMED-mail about us membership programs publications resources 11th ICID site map
11th ICID - Cancun, Mexico - March 4-7, 2004

Satellite Symposia (Updated 4 February 2004)
Latest Evidence in the Management of Moderate to Severe Intra-abdominal Infections
Friday, March 5, 2004, 07:00 to 08:15hrs,  Room: Coral Gallery
Sponsored by MSD
  • Current Challenges in the Treatment of Community-Acquired Mixed Infections
    Sifuentes Jose, MEXICO
  • Evolving Trends in Resistance
    Carmeli Yehuda, USA
  • Effective Initial Empiric Treatment of IAI
    Guzman Blanco Manuel, VENEZUELA
Meningococcal Disease Prevention - Current Options and Future Prospects
Friday, March 5, 2004, 13:00 to 15:00hrs,  Room: Grand Coral Ballroom 1
Sponsored by Chiron Vaccines
  • Global Epidemiology of Meningococcal Disease and Vaccine Efficacy
    Pollard Andrew J., UNITED KINGDOM
  • Meningococcal C Vaccines: The Canadian Experience
    De Wals Philippe, CANADA
  • The Future of Meningococcal Vaccines
    Danzig Lisa, USA
  • The Strategy to Control New Zealand's Epidemic of Group B Meningococcal Disease
    O'Hallahan Jane, NEW ZEALAND
New Insights in the Treatment of Severe Infections in the Multiple-Drug Resistant Situation
Friday, March 5, 2004, 13:00 to 15:00hrs,  Room: Grand Coral Ballroom 3
Sponsored by Daiichi Pharmaceutical Co., Ltd.
  • Comparative Antimicrobial Susceptibility of Respiratory Tract Pathogens
    Felmingham David, UNITED KINGDOM
  • Experience with Levofloxacin in a Critical Pathway for the Treatment of Community-acquired Pneumonia
    Marrie Thomas J., CANADA
  • Clinical Applications of Levofloxacin in Severe Infections
    Graninger Wolfgang, AUSTRIA
  • New Insights in the Treatment with Levofloxacin
    File Thomas, USA
return to top
Invasive Fungal Infections: A Worldwide Problem
Friday, March 5, 2004, 18:00 to 20:00hrs,  Room: Grand Coral Ballroom 1
Sponsored by Pfizer, Inc.
  • Early Management Options for Serious Fungal Infections
    Wingard John, USA
  • Therapy of Invasive Aspergillosis: Timing Is Everything
    de Pauw Ben, NETHERLANDS
  • The Impact of Endemic Fungal Pathogens in the Americas
    Telles Flavio Q., BRAZIL
  • Clinical Significance of Fungal Melanization
    Casadevall Arturo, USA
Defining the Need for New Antibiotics in the Age of Bacterial Resistance
Friday, March 5, 2004, 18:00 to 20:00hrs,  Room: Grand Coral Ballroom 3
Supported by an educational grant from Wyeth
  • Practical Implications of the Epidemiology of Drug-resistant Bacteria
    Canton Rafael, SPAIN
  • The Impact of Early and Appropriate Antibiotic on Patient Outcomes
    Rodriguez Noriega Eduardo, MEXICO
  • Integrating Antibiotics into Early Goal-directed Therapy (EGDT)
    Albertson Timothy, USA
  • An Overview of New and Investigational Antibiotics for Patients with Serious Infections
    Carlet Jean, FRANCE
Reassessing AECB Therapy - The Impact of New Clinical Findings
Saturday, March 6, 2004, 06:45 to 08:15hrs,  Room: Coral Gallery
Sponsored by Bayer HealthCare
  • COPD - The Unrecognized Burden
    Miravitlles Marc, SPAIN
  • Preserving the Efficacy of Antimicrobials
    Amabile-Cuevas Carlos, MEXICO
  • Short- and Long-term Outcomes - The MOSAIC Study
    Anzueto Antonio, USA
Meningococcal Update: Prevalence and Prevention
Saturday, March 6, 2004, 13:00 to 15:00hrs,  Room: Grand Coral Ballroom 1
Sponsored by Baxter BioScience, Vaccines
  • Bacterial Meningitis in Children and Young Adults in Latin America
    Farhat Calil, BRAZIL
  • Group C Meningococcal Polysaccharide-Tetanus Toxoid (GCMP-TT) Conjugate Vaccine (NeisVac-C): Clinical Update
    Ehrlich Hartmut, AUSTRIA
  • Introduction of Meningococcal C Conjugate Vaccines: An Australian Perspective
    Richmond Peter, AUSTRALIA
return to top
Optimizing Outcomes in MRSA Infections: Focus on Nosocomial Pneumonia and Skin and Soft Tissue Infections (SSTI)
Saturday, March 6, 2004, 13:00 to 15:00hrs,  Room: Grand Coral Ballroom 3
Sponsored by Pfizer, Inc.
  • Demystifying the Research: What the Clinician Needs to Know about Resistance
    Stevens Dennis, USA
  • Successful Strategies for Improving Survival in Nosocomial Pneumonia
    Rello Jordi, SPAIN
  • A Practical Guide to the Management of Complicated Skin and Soft Tissue Infections (SSTIs)
    Wilson Samuel E., USA
  • Summary - Staphylococcal Infections: What Does the Future Look Like?
    Stevens Dennis, USA
On the Road towards Universal Mass Vaccination against Hepatitis A
Saturday, March 6, 2004, 18:00-20:00hrs,  Room: Grand Coral Ballroom 1
Sponsored by GlaxoSmithKline Biologicals Division
  • Review of Current Experience with Hepatitis A Universal Mass Vaccination
    Andre Francis, BELGIUM
  • Combined Hepatitis A & B Vaccines: The Tool to Achieve UMV?
    Salleras Louis, SPAIN
  • Burden of Hepatitis A in Latin America
    Ramonet Margarita, ARGENTINA
  • Is Hepatitis A UMV Cost-effective?
    Valenzuela Maria, CHILE
return to top



ProMED-mail | about us | membership | programs | publications
IMED | 14th ICID | site map | home
9 Babcock Street, Unit 3, Brookline MA 02446-5903 · USA
Phone: (617) 277-0551 · Fax: (617) 278-9113 · info@isid.org
Contact Us

©2001-2010 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.